Gossamer Bio, Inc. (GOSS) Stock Jumps 18% on FDA Updates and Seralutinib Progress
Gossamer Bio, Inc.
Gossamer Bio Inc. (GOSS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Octagon Capital Advisors Ting Jia | 17,050,000 | $44,841,500 | -8% | 6.8% |
| 2. | 27,860,000 | $19,716,021 | 0.51% | ||
| 3. | 24,540,000 | $17,239,350 | 0.01% | ||
| 4. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 6,130,268 | $16,122,605 | 2.1% | |
| 5. | Palo Alto Investors William Leland Edwards | 5,464,349 | $14,371,238 | -5% | 2.66% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.92 | 26,050 | $50,016.00 | 58,050 | 2025-08-19 | Filing | |
| $0.67 | 372,000 | $250,281.60 | 5,408,073 | 2024-06-21 | Filing | |
| $0.59 | 100,000 | $59,110.00 | 480,010 | 2024-06-18 | Filing | |
| $0.60 | 25,000 | $15,050.00 | 25,000 | 2024-06-17 | Filing | |
| $0.79 | 32,000 | $25,212.80 | 32,000 | 2023-11-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.66 | 1,908 | $1,260.23 | 196,891 | 2024-06-24 | Filing | |
| $1.16 | 6,430 | $7,429.87 | 585,934 | 2024-03-27 | Filing | |
| $1.16 | 6,430 | $7,430.51 | 92,737 | 2024-03-27 | Filing | |
| $1.16 | 23,172 | $26,772.93 | 120,293 | 2024-03-27 | Filing | |
| $1.33 | 4,018 | $5,341.93 | 198,799 | 2024-03-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,093,034 | $47,584,679 | 2.61% | |
| 2. | 13,846,054 | $36,415,120 | 0% | |
| 3. | 12,009,773 | $31,585,704 | 0% | |
| 4. | 8,055,916 | $21,187,059 | 4.3% | |
| 5. | 30,005 | $20,834,722 | 0.64% |
News See All
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
H.C. Wainwright Asserts Buy Stance on Gossamer Bio Inc. (GOSS) on Pulmonary Arterial Hypertension Drug Prospects
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best Robinhood penny stocks to invest in. The stock has shown strong momentum, rallying by more than 100% year to date.
Piper Sandler Reiterates Buy as Seralutinib Momentum Boosts Gossamer (GOSS) Multibagger Case
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best multibagger stocks to invest in right now.
10 Best Robinhood Penny Stocks to Invest In
Sentiments in the equity markets are at an all-time high, with major indices, such as the S&P 500, at record highs.
15 Best Multibagger Stocks to Invest in Right Now
Just as a single diamond can outshine a handful of pebbles, a well-chosen multibagger can transform an ordinary portfolio into an extraordinary one.
11 Best Rising Penny Stocks to Buy According to Hedge Funds
On August 22, Tom Lee, Fundstrat's head of research and chief investment officer, appeared on CNBC Television to discuss his reaction to Fed Chair Powell's speech at Jackson Hole, market expectations, ...
H.C. Wainwright and Leerink Partners Reiterate ‘Buy’ Ratings on Gossamer Bio, Inc. (GOSS)
On August 7, 2025, H.C. Wainwright reiterated its ‘Buy’ rating on Gossamer Bio, Inc. (NASDAQ:GOSS) with a $10 price target.
11 Best Single Digit Stocks to Buy According to Hedge Funds
The winning streak of U.S. stocks extended on Wednesday, August 13, 2025, with the S&P 500 and Nasdaq reaching fresh record highs for the second day in a row.
Scotiabank Initiates Outperform on Gossamer Bio (GOSS) with an $11 PT, Highlights Potential of PAH Drug Seralutinib
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the biotech stocks to buy according to Wall Street analysts.